Patients' Perspectives on Psychiatric Pharmacogenetic Testing
Affiliations
- PMID: 32583391
- DOI: 10.1055/a-1183-5029
Abstract
Introduction: There is growing interest to adopt pharmacogenetic (PGx) testing in psychiatric medicine, despite mixed views regarding its clinical utility. Nevertheless, providers are utilizing PGx testing among patients with mental health disorders. This study sought to assess genotyped patients' perspectives and experiences with psychiatric PGx testing.
Methods: Individual semi-structured interviews were conducted among patients with depression who had undergone psychiatric PGx testing. The audio-recorded interviews were transcribed and analyzed inductively and deductively for salient themes.
Results: Twenty patients (100% Caucasian, 60% female, mean age 39±18 years) were interviewed. The majority of the PGx tests were provider-initiated for patients who failed multiple pharmacotherapies (50%) and/or had medication intolerances (45%). Patients' pre-testing expectations ranged from hopefulness to indifference to skepticism. Their post-testing experiences varied from optimism to disappointment, with the perceived value of the test influenced by the results and cost of the test.
Discussion: Genotyped patients had mixed perspectives, expectations, and experiences with psychiatric PGx testing. Their perceived value of the test was influenced by the test outcomes and its cost.
© Georg Thieme Verlag KG Stuttgart · New York.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
- Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.Pharmacogenomics. 2019 Dec;20(18):1291-1302. doi: 10.2217/pgs-2019-0129. Epub 2019 Nov 22.PMID: 31755847
- Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework.J Clin Med. 2020 Mar 17;9(3):814. doi: 10.3390/jcm9030814.PMID: 32192029 Free PMC article.
- Primary care physician experiences with integrated pharmacogenomic testing in a community health system.Per Med. 2017 Sep;14(5):389-400. doi: 10.2217/pme-2017-0036. Epub 2017 Aug 2.PMID: 29754567
- Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.Genet Res (Camb). 2015 Jun 1;97:e13. doi: 10.1017/S0016672315000099.PMID: 26030725 Free PMC article. Review.
- Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.Patient Educ Couns. 2014 Oct;97(1):10-5. doi: 10.1016/j.pec.2014.06.007. Epub 2014 Jun 21.PMID: 24985359 Free PMC article. Review.
No hay comentarios:
Publicar un comentario